Yanqiao Zhang
Yanqiao Zhang publishes mostly in Oncology, Molecular Biology and Cancer Research, on topics such as Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies and Pancreatic and Hepatic Oncology Research.
- World rank
- #88,816 of 7,710,434 ranked researchers
- Rank in China
- #7,440 of 978,568
- Works
- 397
- Citations
- 8.9k
- Citations per work
- 22.4
What does Yanqiao Zhang research?
Yanqiao Zhang's work is mostly in Medicine (43%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences17042.8%
- Medicine17042.8%
- Life Sciences11829.6%
- Everything else11027.6%
- 1Oncology26% of their works
- 2Molecular Biology16% of their works
- 3Cancer Research10% of their works
- 4Pulmonary and Respiratory Medicine8% of their works
- 5Surgery8% of their works
- 6Immunology4% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Cancer-related molecular mechanisms research
- Hepatocellular Carcinoma Treatment and Prognosis
- Esophageal Cancer Research and Treatment
- HER2/EGFR in Cancer Research
Which keywords describe Yanqiao Zhang's research?
The keywords of their largest research topics: Chemotherapy, Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Neoadjuvant Therapy, Clinical Practice Guidelines, Endoscopic Resection and Cetuximab.
- Breast Cancer
- Esophageal Carcinoma
- Liver Cancer
- Cancer
- Gastric Cancer
- Pancreatic Cancer
- Cetuximab
- Clinical Practice Guidelines
- PD-1 and PD-L1
- Tumor Microenvironment
- Chemotherapy
- Immune Checkpoint Blockade
- Neoadjuvant Therapy
- Endoscopic Resection
- KRAS Mutations
- Surgical Complications
- Molecular Characterization
- Hepatocellular Carcinoma
- Long Noncoding RNAs
- Preoperative Chemoradiotherapy
- HER2
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy864 topics
- Tumor Microenvironment682 topics
- Immune Checkpoint Blockade431 topic
- PD-1 and PD-L1431 topic
- Neoadjuvant Therapy402 topics
- Clinical Practice Guidelines352 topics
- Endoscopic Resection342 topics
- Cetuximab291 topic
- KRAS Mutations291 topic
- Pancreatic Cancer251 topic
- Surgical Complications251 topic
- Gastric Cancer191 topic
- Molecular Characterization191 topic
- Cancer161 topic
- Hepatocellular Carcinoma161 topic
- Liver Cancer161 topic
- Long Noncoding RNAs161 topic
- Esophageal Carcinoma151 topic
- Preoperative Chemoradiotherapy151 topic
- Breast Cancer131 topic
- HER2131 topic
Where does Yanqiao Zhang work?
Yanqiao Zhang's main affiliation in the publication record is Harbin Medical University, China.
How many publications and citations does Yanqiao Zhang have?
OpenAlex counts 397 works and 8,903 citations for Yanqiao Zhang, an h-index of 43, ranking #88,816 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Yanqiao Zhang
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yanqiao Zhang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.